BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Treatment
3250 results:

  • 1. A Comparative Analysis of Implant-sparing Plan
    Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
    In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Inhibition of MMP-2 and MMP-9 by Dietary Antioxidants in THP-1 Macrophages and Sera from Patients with breast cancer.
    Latronico T; Petraglia T; Sileo C; Bilancia D; Rossano R; Liuzzi GM
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675538
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship: Protocol for a Measurement Burst Study.
    Cho D; Roth M; Peterson SK; Jennings K; Kim S; Weathers SP; Ahmed S; Livingston JA; Barcenas C; You YN; Milbury K
    JMIR Res Protoc; 2024 Apr; 13():e53307. PubMed ID: 38652520
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Neighborhood Disadvantage and breast cancer-Specific Survival in the US.
    Goel N; Hernandez AE; Mazul A
    JAMA Netw Open; 2024 Apr; 7(4):e247336. PubMed ID: 38635268
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Omitting Axillary Dissection in breast cancer with Sentinel-Node Metastases.
    de Boniface J; Filtenborg Tvedskov T; Rydén L; Szulkin R; Reimer T; Kühn T; Kontos M; Gentilini OD; Olofsson Bagge R; Sund M; Lundstedt D; Appelgren M; Ahlgren J; Norenstedt S; Celebioglu F; Sackey H; Scheel Andersen I; Hoyer U; Nyman PF; Vikhe Patil E; Wieslander E; Dahl Nissen H; Alkner S; Andersson Y; Offersen BV; Bergkvist L; Frisell J; Christiansen P; ;
    N Engl J Med; 2024 Apr; 390(13):1163-1175. PubMed ID: 38598571
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A cross-sectional study of sleep disturbance among middle-aged cancer patients at Vietnam National cancer Hospital.
    Pham AT; Do MT; Tran HTT
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2055. PubMed ID: 38577715
    [TBL] [Abstract] [Full Text] [Related]  

  • 7.
    Diwanji D; Onishi N; Hathi DK; Lawhn-Heath C; Kornak J; Li W; Guo R; Molina-Vega J; Seo Y; Flavell RR; Heditsian D; Brain S; Esserman LJ; Joe BN; Hylton NM; Jones EF; Ray KM
    Radiol Imaging Cancer; 2024 Mar; 6(2):e230082. PubMed ID: 38551406
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cardiovascular/anti-inflammatory drugs repurposed for treating or preventing cancer: A systematic review and meta-analysis of randomized trials.
    Benjamin DJ; Haslam A; Prasad V
    Cancer Med; 2024 Mar; 13(5):e7049. PubMed ID: 38491813
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial.
    Huang L; Pang D; Yang H; Li W; Wang S; Cui S; Liao N; Wang Y; Wang C; Chang YC; Wang HC; Kang SY; Seo JH; Shen K; Laohawiriyakamol S; Jiang Z; Wang H; Lamour F; Song G; Curran M; Duan C; Lysbet de Haas S; Restuccia E; Shao Z
    Nat Commun; 2024 Mar; 15(1):2153. PubMed ID: 38461323
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Synthesis of Indole-Linked Thiadiazoles and their Anticancer Action against Triple-Negative breast cancer.
    Gavadia R; Rasgania J; Sahu N; Nimesh S; Loveleen L; Mor S; Jakhar K
    Chem Biodivers; 2024 Apr; 21(4):e202302000. PubMed ID: 38427723
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of new 5-(2,6-dichlorophenyl)-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-7-carboxylic acids as p38α MAPK inhibitors: Design, synthesis, antitumor evaluation, molecular docking and in silico studies.
    El-Wakil MH; El-Dershaby HA; Ghazallah RA; El-Yazbi AF; Abd El-Razik HA; Soliman FSG
    Bioorg Chem; 2024 Apr; 145():107226. PubMed ID: 38377818
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16).
    Colombo I; Koster KL; Holer L; Haefliger S; Rabaglio M; Bastian S; Schwitter M; Eckhardt K; Hayoz S; Mc Laughlin AM; Kloft C; Klose M; Halbherr S; Baumgartner C; Sessa C; Stathis A; Hess D; Joerger M
    Eur J Cancer; 2024 Apr; 201():113588. PubMed ID: 38377773
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Circulating Leukocyte Subsets Before and After a breast cancer Diagnosis and Therapy.
    Kresovich JK; O'Brien KM; Xu Z; Weinberg CR; Sandler DP; Taylor JA
    JAMA Netw Open; 2024 Feb; 7(2):e2356113. PubMed ID: 38358741
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Effects of Extended Fixation on Advanced Gastric cancer HER2 Status Assessment Using IHC and FISH.
    Kondo J; Yoshino S; Iida M; Takeda S; Nakashima C; Watanabe Y; Nishiyama M; Tokumitsu Y; Shindo Y; Nishimura T; Suzuki N; Hoshii Y; Itoh H; Nagano H
    Anticancer Res; 2024 Feb; 44(2):621-630. PubMed ID: 38307565
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Patient survey on cancer genomic medicine in Japan under the national health insurance system.
    Kage H; Akiyama N; Chang H; Shinozaki-Ushiku A; Ka M; Kawata J; Muto M; Okuma Y; Okita N; Tsuchihara K; Kikuchi J; Shirota H; Hayashi H; Kokuryo T; Yachida S; Hirasawa A; Kubo M; Kenmotsu H; Tanabe M; Ushiku T; Muto K; Seto Y; Oda K
    Cancer Sci; 2024 Mar; 115(3):954-962. PubMed ID: 38273803
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Long-term outcomes with HLX01 (HanliKang
    Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
    BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Therapy-induced senescent cancer cells exhibit complement activation and increased complement regulatory protein expression.
    Abu-Humaidan AH; Ismail MA; Ahmad FM; Al Shboul S; Barham R; Tadros JS; Alhesa A; El-Sadoni M; Alotaibi MR; Ababneh NA; Saleh T
    Immunol Cell Biol; 2024 Apr; 102(4):240-255. PubMed ID: 38265162
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
    King B; Soung J; Tziotzios C; Rudnicka L; Joly P; Gooderham M; Sinclair R; Mesinkovska NA; Paul C; Gong Y; Anway SD; Tran H; Wolk R; Zwillich SH; Lejeune A
    Am J Clin Dermatol; 2024 Mar; 25(2):299-314. PubMed ID: 38263353
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Bladder-Preserving Trimodality Therapy With Capecitabine.
    Lynch C; Sweis RF; Modi P; Agarwal PK; Szmulewitz RZ; Stadler WM; O'Donnell PH; Liauw SL; Pitroda SP
    Clin Genitourin Cancer; 2024 Apr; 22(2):476-482.e1. PubMed ID: 38228414
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Analysis of breast cancer Mortality in the US-1975 to 2019.
    Caswell-Jin JL; Sun LP; Munoz D; Lu Y; Li Y; Huang H; Hampton JM; Song J; Jayasekera J; Schechter C; Alagoz O; Stout NK; Trentham-Dietz A; Lee SJ; Huang X; Mandelblatt JS; Berry DA; Kurian AW; Plevritis SK
    JAMA; 2024 Jan; 331(3):233-241. PubMed ID: 38227031
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 163.